Inter-software variability in post-implanted CT analysis for interstitial permanent brachytherapy for prostate cancer: Differences in automatically detected seed location

Radiotherapy and Oncology

Volumn 89, Issue 2, 2008, Pages 214-216

  Ishiyama, Hiromichi ^a   Nakamura, Ryuji ^b   Satoh, Takefumi ^a   Tanji, Susumu ^b   Uemae, Mineko ^c   Baba, Shiro ^a   Hayakawa, Kazushige ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Radiology ^*  (Japan)

^c KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

125 I; Brachytherapy; Inter software variability; Post plan; Prostate cancer

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; HISTOGRAM; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RADIATION DOSE; URETHRA;

BRACHYTHERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55149083732     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.07.001     Document Type: Article

References (12)

1. Zelefsky M.J., Wallner K.E., Ling C.C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 17 (1999) 517-522
2. Zelefsky M.J., and Whitmore W.F. Long-term results of retropubic permanent I-125 implantation of the prostate for clinically localized prostate cancer. J Urol 158 (1997) 23-29
3. Downs T.M., Sadetsky N., Pasta D.J., et al. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer-data from CaPSURE. J Urol 170 (2003) 1822-1827
4. Van Gellekom M.P.R., Moerland M.A., Van Vulpen M., et al. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry. Int J Radiat Oncol Biol Phys 63 (2005) 772-780
5. Namiki S., Satoh T., Baba S., et al. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study. J Urol 68 (2006) 1230-1236
6. Battermann J.J., Boon T.A., and Moerland M.A. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 71 (2004) 23-28
7. Blank L.E., Gonzalez Gonzalez D., de Reijke T.M., et al. Brachytherapy with transperineal (125) Iodine seeds for localized prostate cancer. Radiother Oncol 57 (2000) 307-313
8. Potters L., Klein E.A., Kattan M.W., et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71 (2004) 29-33
9. Nag S., Bice W., DeWyngaert K., Prestidge B., Stock R., and Yu Y. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 46 (2000) 221-230
10. Kirisits C., Siebert F., Baltas D., et al. Accuracy of volume and DVH parameters determined with different brachytherapy treatment planning systems. Radiother Oncol 84 (2007) 290-297
11. Siebert F., De Brabandere M., Kirisits C., et al. Phantom investigations on CT seed imaging for interstitial brachytherapy. Radiother Oncol 85 (2007) 316-323
12. Rivard M.J., Coursey B.M., Deward L.A., et al. Update of AAPM Task Group No. 43 report: a revised AAPM protocol for brachytherapy dose calculations. Int J Radiat Oncol Biol Phys 57 suppl2 (2003) S430